![Arul Chinnaiyan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arul Chinnaiyan
Corporate Officer/Principal chez
University of Michigan
Profil
Arul M.
Chinnaiyan is the founder of Oncofusion Therapeutics, Inc., founded in 2012.
Dr. Chinnaiyan was the founder of Lynx Dx, Inc., founded in 2019, and held the title of President & Director.
Dr. Chinnaiyan is also the founder of Esanik Therapeutics, Inc...
Dr. Chinnaiyan currently holds the position of Professor at the University of Michigan.
Dr. Chinnaiyan currently serves as an Advisor at Brightedge Ventures.
Postes actifs de Arul Chinnaiyan
| Sociétés | Poste | Début |
|---|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 11/03/2010 |
Brightedge Ventures
 Brightedge Ventures Investment ManagersFinance Brightedge Ventures invests in companies located in the United States. The firm targets companies operating in the fields of cancer focused therapies and technology sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Arul Chinnaiyan
| Sociétés | Poste | Fin |
|---|---|---|
Lynx Dx, Inc.
 Lynx Dx, Inc. Medical SpecialtiesHealth Technology Manufactures and sells diagnostic tools | Fondateur | - |
Esanik Therapeutics, Inc.
 Esanik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Offers neuroscience research and drug development | Fondateur | - |
Oncofusion Therapeutics, Inc.
 Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops personalized therapeutics for patients with genetically defined cancers | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops personalized therapeutics for patients with genetically defined cancers | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brightedge Ventures
Brightedge Ventures Investment ManagersFinance Brightedge Ventures invests in companies located in the United States. The firm targets companies operating in the fields of cancer focused therapies and technology sectors. It provides financing for early stage capital requirements. | Finance |
Lynx Dx, Inc.
Lynx Dx, Inc. Medical SpecialtiesHealth Technology Manufactures and sells diagnostic tools | Health Technology |
Esanik Therapeutics, Inc.
Esanik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Offers neuroscience research and drug development | Commercial Services |
Choisissez Zonebourse 
